San Diego Pharmaceutical / Pharmacy Conference San Diego, USA

Overview: This year’s multi-streamed sessions include: • Controlled and modified release technologies for product lifecycle extensions • Development and optimization of protein formulations • Preventing aggregation and ensuring stability in biologic formulation • Out-sourcing and in-licensing • Regulatory viewpoint on partnerships and safeguarding intellectual property • Managing relationships in drug delivery partnerships – effective deal structures • Applications of nanotechnology and ...more

The 2012 AAPS National Biotechnology Conference presentations and discussions should be of interest to scientists who are devoted to advancing health through innovations in biotherapeutics. The scientific programming will feature 19 symposia, 16 roundtables and mini-symposia, 8 sunrise sessions and 3 short courses. All sessions are planned around the following themes: • Antibody Drug Conjugates • Bioanalysis • Biosimilar/Biobetters • Biotherapeutics Drug Development • Biotherapeutics Drug ...more

Hear top experts in the industry discuss the hottest issues effecting pharmaceutical publication planning today. TIPPA’s 10th Annual Meeting provides a forum for pharmaceutical communications professionals to discuss the current changes and challenges affecting publication planning, while promoting lively and constructive discourse from multiple perspectives. TIPPA's Executive Board of industry leaders has helped to design an agenda that will provide you with indispensible takeaways on ...more

As biotech products progress from the simple to the complex, so do the demands of the clients for more higher-end, greater value-added activities from their manufacturing counterparts, whether internal or external.Transfers from lab to pilot plant or from clinical to commercial manufacturing have never been more challenging. Not only are there more regulatory oversight, shorter schedules and higher expectations, the suppliers network is more diverse than ever. Brought on by the major M&As over ...more

Next Event to Take Place April 17-19, 2012 in San Diego, CA. On April 12 of this year, Drug Discovery Chemistry 2011 convened in San Diego, California. 400 participants from 17 countries, and over 200 companies, spent three days networking and discussing novel small molecules as therapeutic targets, as well as, case studies, and best practices. Each program at Drug Discovery Chemistry 2011 featured presentations and discussions offering different views and perspectives on poignant issues ...more

Finding Fragments by various screening methods has become an established practice. Each of the technologies used have a different set of advantages and disadvantages. Questions such as how to select the most suitable projects, how and when to use screening methods such as crystallography, NMR, SPR or mass spec either as a standalone technique or in combination and how to correctly predict binding at active sites will be addressed in this meeting. In addition, new challenges are arising and ...more

Event Highlights: 6 Conferences, ONE Locations! Panel & Roundtable Discussions Over 70 Presentations Scientific Posters Short Courses...more

Overview: This year’s multi-streamed sessions include: • Controlled and modified release technologies for product lifecycle extensions • Development and optimization of protein formulations • Preventing aggregation and ensuring stability in biologic formulation • Out-sourcing and in-licensing • Regulatory viewpoint on partnerships and safeguarding intellectual property • Managing relationships in drug delivery partnerships – effective deal structures • Applications of nanotechnology and ...more

The 2012 AAPS National Biotechnology Conference presentations and discussions should be of interest to scientists who are devoted to advancing health through innovations in biotherapeutics. The scientific programming will feature 19 symposia, 16 roundtables and mini-symposia, 8 sunrise sessions and 3 short courses. All sessions are planned around the following themes: • Antibody Drug Conjugates • Bioanalysis • Biosimilar/Biobetters • Biotherapeutics Drug Development • Biotherapeutics Drug ...more